EXAC - 25780

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
CategoryN/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (3Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • Genomic Health (GHDX) to Join Exact Sciences, Posts Q2 Results
    Zacks

    Genomic Health (GHDX) to Join Exact Sciences, Posts Q2 Results

    The merger of Genomic Health (GHDX) with Exact Sciences will combine two of the strongest brands in cancer diagnostics, Cologuard and OncotypeDX, providing platform for growth.

  • Moody's

    Exactech, Inc. -- Moody's announces completion of a periodic review of ratings of Exactech, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Exactech, Inc. New York, June 24, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Exactech, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • We're sorry this is all we were able to find about this topic.